Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 24, 2026
Financial Institutions (FISI) Delivers Strong Q2 2026 Earnings Beat with Margin Expansion and Record AUM

Financial Institutions (FISI) Delivers Strong Q2 2026 Earnings Beat with Margin Expansion and Record AUM

Key Takeaways

  • Q2 2026 diluted earnings per share (EPS) of $1.04 beat the consensus analyst estimate of $0.93 by $0.11, marking a 22.4% increase from $0.85 in the same quarter last year.
  • Net income available to common shareholders rose 21.3% year-over-year to $20.8 million, driven by record net interest income of $53.4 million and sustained expense discipline.
  • Total loans grew 2.7% sequentially to $4.75 billion, fueled by robust commercial lending activity in Western and Central New York markets.
  • Courier Capital's assets under management (AUM) surpassed $4.0 billion for the first time, supported by new business activity and favorable market performance.
  • Net interest margin expanded to 3.70%, up 21 basis points from the prior-year quarter, reflecting effective management of funding costs.
  • The efficiency ratio improved to 55.33% from 59.68% a year ago, underscoring the company's ability to generate stronger revenue while holding noninterest expenses flat.

Putting FISI’s Results in Context

Financial Institutions, Inc. (FISI), the parent company of Five Star Bank and wealth manager Courier Capital, entered the second quarter of 2026 with solid momentum following a strong start to the year. The regional banking sector has been navigating a mixed-rate environment, deposit competition, and lingering credit quality concerns. Against that backdrop, FISI's Q2 results offer a snapshot of how a well-capitalized community bank with a growing wealth management franchise can deliver profitable expansion. Investors were closely watching for signs that commercial loan pipelines remain healthy and that net interest margin (NIM) — the difference between what a bank earns on loans and pays on deposits — can continue expanding even as the rate cycle evolves. The company's performance in both areas makes this earnings report a meaningful indicator of its ability to sustain above-peer profitability.

Breaking Down the Reported Numbers

Financial Institutions, Inc. reported net income of $21.2 million for the second quarter ended June 30, 2026, compared to $21.0 million in the first quarter of 2026 and $17.5 million in the second quarter of 2025. After preferred stock dividends, net income available to common shareholders was $20.8 million, or $1.04 per diluted share. That result comfortably exceeded the Wall Street consensus estimate of $0.93 per share, according to data compiled by Investing.com and Zacks. Total revenue, which combines net interest income and noninterest income, reached approximately $64.3 million, also ahead of the consensus forecast of roughly $63.4–$63.5 million.

Net interest income hit a new quarterly record of $53.4 million, an 8.6% increase from $49.1 million in the second quarter of 2025. The net interest margin on a tax-equivalent basis was 3.70%, expanding 3 basis points from the linked quarter and 21 basis points year-over-year. Management attributed the NIM improvement primarily to lower interest-bearing liability costs, with the cost of interest-bearing liabilities declining to 2.61% — down 4 basis points sequentially and 39 basis points from a year ago.

Noninterest income totaled $11.0 million, up 2.6% from the first quarter and 3.2% year-over-year. Investment advisory fees increased 7.4% sequentially and 13.9% year-over-year, reflecting Courier Capital's milestone of crossing $4.0 billion in AUM. Income from derivative instruments also contributed positively.

On the expense side, noninterest expense was essentially flat at $35.6 million in both the first and second quarters of 2026, and slightly lower than the $35.7 million reported in the second quarter of 2025. Salaries and employee benefits rose modestly due to annual merit increases and an additional business day, while computer and data processing expenses declined meaningfully due in part to the termination of a vendor relationship earlier in the year.

From a credit quality standpoint, net charge-offs were 0.11% of average loans on an annualized basis, a sharp improvement from 0.44% in the first quarter of 2026. The allowance for credit losses on loans to total loans ratio stood at 1.00%. Non-performing loans represented 0.82% of total loans at quarter-end.

To compare FISI with other regional banks on key metrics, I also checked this using Tickeron’s AI Screener.

Market Reaction and Investor Sentiment

Shares of FISI closed at $38.72 on July 23, 2026, down 0.44% on the day ahead of the after-market earnings release. The muted pre-release trading suggested a degree of caution, though the company had beaten consensus EPS estimates in three of the prior four quarters. Year-to-date, the stock has risen approximately 24%, outperforming the broader NASDAQ Composite Index. Preliminary after-hours trading showed the stock at $38.70 following the release, indicating a relatively measured initial reaction. With the earnings conference call scheduled for July 24 at 8:30 a.m. Eastern Time, management's commentary on the forward outlook will likely be the next key driver of sentiment. The combination of a double-digit earnings beat, record AUM in the wealth business, and an improving efficiency ratio positions the company favorably, though ongoing deposit cost pressures and broader regional bank sector volatility remain factors that investors are weighing.

Forward Outlook and Key Factors to Monitor

Looking ahead, several themes will shape the investment narrative around Financial Institutions, Inc. The company reaffirmed its full-year 2026 loan growth target of 5%, supported by a commercial lending pipeline that management previously characterized as robust — approximately $950 million in potential opportunities, up from around $650 million at year-end 2025. Achieving that target will depend on continued economic activity in the company's core Western and Central New York markets and its Mid-Atlantic commercial lending footprint.

On the margin front, management had previously guided toward a full-year NIM in the "upper 360s" (i.e., the upper end of the 3.60%–3.69% range), and the Q2 result of 3.70% already meets or exceeds that threshold. Investors will listen closely for any updates or upward revisions to that guidance on the conference call. Deposit costs appear to be stabilizing, which could provide a tailwind if the Federal Reserve maintains or begins to lower rates in the second half of the year.

In the wealth management segment, Courier Capital's AUM crossing the $4.0 billion milestone signals growing diversification of the company's revenue base. Investment advisory fees provide a recurring, capital-light income stream that partially offsets the cyclicality of net interest income. Continued growth in this segment would support a higher quality of earnings over time.

Credit quality warrants continued monitoring. While net charge-offs improved dramatically quarter-over-quarter, non-performing loans rose year-over-year, partly due to one well-collateralized commercial relationship that moved to nonaccrual status earlier in 2026. The allowance for credit losses on loans stood at 1.00% of total loans, and management has previously guided toward full-year net charge-offs in the range of 25–35 basis points. Staying within that range will be critical for investor confidence.

Capital management remains a positive element of the story. With a common equity Tier 1 (CET1) ratio — a key measure of a bank's financial strength — of 11.44%, tangible common book value per share of $28.72, and approximately half of the existing share repurchase authorization remaining, the company has flexibility to continue returning capital to shareholders through buybacks and dividends.

Using AI Tools for Deeper Banking Sector Analysis

When evaluating opportunities in the regional banking space, I often turn to Tickeron’s AI Screener for a data-driven view. The platform lets me filter stocks and ETFs by technical patterns, fundamentals, volatility, and AI signals, which helps surface comparable names and breakout ideas more efficiently than manual screening. For a stock like FISI, it provides quick context on how it measures up to peers in areas such as margin trends and efficiency, supporting a more informed review of the earnings story without replacing traditional fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FISI

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


FISI's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for FISI moved out of overbought territory on August 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 instances where the indicator moved out of the overbought zone. In of the 34 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where FISI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FISI as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FISI turned negative on August 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FISI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FISI broke above its upper Bollinger Band on July 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FISI advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 239 cases where FISI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.318) is normal, around the industry mean (1.352). P/E Ratio (10.390) is within average values for comparable stocks, (24.299). FISI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.846). Dividend Yield (0.030) settles around the average of (0.031) among similar stocks. P/S Ratio (3.317) is also within normal values, averaging (3.855).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 55, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FISI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are PNC Financial Services Group (NYSE:PNC), US Bancorp (NYSE:USB), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.5B. The market cap for tickers in the group ranges from 10.73K to 142.82B. CIHHF holds the highest valuation in this group at 142.82B. The lowest valued company is ACBCQ at 10.73K.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was -0%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 12%. CCB experienced the highest price growth at 12%, while NEWT experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 52
Price Growth Rating: 47
SMR Rating: 53
Profit Risk Rating: 55
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
FISI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a regional bank

Industry RegionalBanks

Profile
Details
Industry
Regional Banks
Address
220 Liberty Street
Phone
+1 585 786-1100
Employees
631
Web
https://www.FISI-investors.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.